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The aim of this work is to estimate the excipient percolation threshold f or a new combined matrix 
native dextran (DT), series B110-1-2 (Mw 2 x 106): HPMC K4M CR: lobenzarit disodium (LBD) system 
and demonstrate the advantages of this ternary system with respect to previously reported binary dex­
tran:LBD and HPMC:LBD tablets. The formulations studied were prepared with different amounts of 
excipient(DT:HPMC, 4: 1 (wt/wt) for ail tablets and relative polymer/drug partide size of 4.17) in the range 
of 10-70% (wt/wt). Dissolution studies were carried out using the paddle method ( 100 rpm) and one face 
water uptake measurements were performed using a modified Enslin apparatus. The Higuchi's models as 
weil as the non-linear regression were employed as empiric methods to study the released data. Values of 
diffusion exponent 0.588 < n < 0.784 (Korsmeyer equation) for dissolution profile and water uptake mech­
anism 0.715 < n < 0.960 (Davidson and Peppas equation) suggests anomalous or complex mechanisms in 
ail cases. The critical points in ternary tablets were reduced from 44.75% (v/v) of excipient (correspond 
to purely native dextran) to 22.34% (v/v) (corresponding to mixture native dextran:HPMC. 4:1, wt/wt). 
The initial porosity (IP) ofhydrophilic matrices above the values of20% has an important influence on the 
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ion theory is a statistical theory that studies disor­
aotic systems where the components are randomly 
in a lattice. It has wide application in many scien­
ines and was introduced in the pharmaceutical field 
rger et al. (1987) to improve the characterization of 
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t al., 1995).
Dextrans can be deﬁned as glucose homopolysaccharides that
eature a substantial number of consecutive -(1→6) linkages
n their major chains, usually more than 50% of the total link-
ges. These -d-glucans possess also side chains stemming from
-(1→2), -(1→3), or -(1→4) branch linkages. Coming from
enewable sources, polysaccharides have frequently also eco-
omical advantages over synthetic polymers. Polysaccharides are
sually non-toxic, biocompatible and show a number of peculiar
hysico-chemical properties that make them suitable for different
pplications in drug delivery systems (Coviello et al., 2007; Robyt,
986).
Hydroxypropylmethylcellulose has been employed extensively
s hydrophilic matrix former in oral controlled release dosage
orms for different drugs. Its popularity can be attributed to the
olymer’s non-toxic nature, small inﬂuence of processing variables
n drug release, ease of compression, and its capability to accom-
odate high levels of drug loading (Bettini et al., 1994).
The percolation theory has been applied to describe controlled
elease inert matrix systems (Caraballo et al., 1993). Recently we
tarted to apply the percolation theory to the study of HPMC
ydrophilic matrix systems. Miranda et al. demonstrated experi-
entally the inﬂuence of the particle size of the components on
he percolation threshold in HPMC hydrophilic matrices (Miranda
t al., 2006a,b, 2007c; Fuertes et al., 2006) and some evidence of
he inﬂuence of the initial porosity in the formation of the gel layer
sample-spanning cluster of excipient) were achieved.
Lobenzarit disodium (LBD) is a drug conceived for the treat-
ent of rheumatoid arthritis. This drug produces an improvement
f immunologic abnormalities and has a regulatory effect upon the
ntibody producing system. It is administered orally in the form of
ablets and its daily dosage is 240mg (80mg three doses per day)
Ohsugi et al., 1985).
The objective of the present work was to estimate the excipient
ercolation threshold for a new combined matrix native dextran
DT), series B110-1-2 (Mw 2×106): HPMC K4M CR: LBD system, to
haracterize its release kinetics and to demonstrate the advantages
f this ternary system with respect to previously reported binary
extran:LBD tablets (CastellanosGil et al., 2008b). At the same time
he inﬂuence of the initial porosity (IP) of hydrophilic matrices
n the range 0–30% on the release and percolation behaviour was
nalyzed.
. Materials and methods
.1. MaterialsCommercial native Dextran B512-F (Mw 5000000–40000000,
ccording to manufacturer’s data and Mw 22000000, according to
iscometer analysis (Castellanos Gil et al., 2008c)) was obtained
rom Sigma (Saint Louis, USA) and used as reference polymer.
t
B
w
p
i
able 1
roperties of LBD tablets (dosage 150mg) at various amounts of polymers mixture DT:HP
Batch (total excipients %, v/v) DT (%, v/v) HPMC (%, v/
DT:HPMC-10 (10.81) 8.59 2.22
DT:HPMC-15 (15.89) 12.63 3.26
DT:HPMC-20 (22.34) 17.75 4.59
DT:HPMC-30 (33.10) 26.30 6.80
DT:HPMC-40 (43.55) 34.60 8.95
DT:HPMC-50 (53.89) 42.81 11.09
DT:HPMC-60 (63.65) 50.57 13.08
DT:HPMC-70 (68.62) 54.52 14.10
a Values expressed the mean of experimental±RSD values for 12 samples.igh molecular weight native dextran (B110-1-2, Mw 2000000
Castellanos Gil et al., 2008c)) was obtained from the Center of
tudies of Sugar Cane (Havana, Cuba). Lobenzarit disodium (LBD)
as prepared in the Synthesis Laboratory at the Center of Pharma-
eutical Chemistry (Cuba).Hydroxypropylmethylcellulose (HPMC)
ith a viscosity grade 4000 cps (Methocel K4M CR) was obtained
rom Colorcon (Kent, England). Other chemicals and reagents were
f analytical grade.
.2. Preparation of matrix tablets
The polymers were sieved (Retsch type Vibro, Germany), the
ranulometric fractions 150–200m were employed and Carr’s
ndex (CI) was calculated. The drug was not sieved but its mean
article size was measured as 42±0.61m using a He–Ne laser
iffraction system (Malvern Instr., type Matersize x, 1.2 b, UK).
he apparent particle density of LBD (2.159g/cm3) and poly-
ers (1.330g/cm3 for DT and 1.285 for HPMC K4M CR) has been
alculated using an air pycnometer (Quantachrome type Stereopy-
ometer spy-3,USA) andnot verydifferent values to those reported
n the literature were achieved (Novoa et al., 1996; Fuertes et al.,
006).
TernarymixturesDT:HPMC:LBDkeeping ratioDT:HPMCalways
s 4:1 (wt/wt), were prepared with varying polymer’s mixture
ontents (10%, 15%, 20%, 30%, 40%, 50%, 60% and 70%, wt/wt) (for
olumetric fraction see Table 1) and with a constant amount of
he drug (150mg dosage) without any further excipient. Binary
ystem DT:LBD was prepared with the same polymer amount
range 10–70%, wt/wt) with respect to LBD according to previously
eported data (Castellanos Gil et al., 2008b). Table 1 also shows the
omposition of the studied batches aswell as the tablet thicknesses
n=12). Tablet components were mixed for 3min (optimal mixing
ime) using a Turbula mixer (Basel, Switzerland).
Tappeddensity andbulk density of polymers andmixtureswere
eterminedaccording to EuropeanPharmacopoeia (PhEur 4, 2002).
pproximately 100ml of powder is gently poured into a tare grad-
ated cylinder and the initial volume and weight of the material
s recorded. The graduated cylinder is placed on a tapped density
ester and the ﬁnal volume is recorded after 500 taps (SBS model.
OL-1 tap density tester) and Carr’s index was obtained (Eq. (1)).
Percent compressibility index
= 100 × tapped density − bulk density
tapped density
(1)
The mixtures were compressed with a F. RASSANT (France)
ydraulic pressﬁttedwith a10mmdiameterﬂat punch. After some
ime (around 10 s) the formed tabletswere ejected from the punch.
asedonprevious studieswhere the inﬂuenceof compression force
as studied as a function of the reduction in volume of dextran
lacebo tablets, compression force 14kN was applied for all exper-
ments in order to minimize initial porosity of tablets (Castellanos
MC (4:1, wt/wt).
v) aTablet weight (mg) aTablet thickness (mm)
166.1 ± 0.9 1.480 ± 0.031
176.2 ± 2.1 1.600 ± 0.025
187.5 ± 1.1 1.618 ± 0.060
214.2 ± 0.9 1.878 ± 0.063
250.0 ± 1.4 2.213 ± 0.065
300.0 ± 1.3 2.683 ± 0.056
375.2 ± 1.3 3.407 ± 0.047
500.1 ± 1.9 4.916 ± 0.078
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ril et al., 2008b,c). Furthermore in order to analyze the inﬂuence
f IP, different and adequate compression forces (range 2–30kN)
ere applied to obtain IP of tablets in the range 0–30%, respec-
ively. All the tablets were tested for friability (Erweka, mod. TAD,
ermany).
.3. In vitro drug release studies
Dissolution studies were carried out at 37±0.5 ◦C in 900ml of
istilled water, in a USP apparatus (SotaxAT7 Smart, Teknokroma,
pain) using the paddle method. The rotation speed was kept
onstant at 100 rpm. Release of LBD was detected by UV spec-
rophotometric method at 360nm during 8h. Three replicates of
ltered samples, taken at different times, were performed for each
etermination and themean valueswere used to obtain the release
roﬁles. The total amount of drug present in the tablets was calcu-
ated as the sum of the cumulative mass of drug released in the last
ample and the mass of drug remaining (residue). The technique
as previously validated. The validationmethodwas carried out by
nalyzing solutions containing several concentrations of LBD inﬁve
eplicates. Furthermore, these solutionswereanalyzedby triplicate
n ﬁve different days (n=15). The results showed a good linearity
r2 =0.9940),with appropriate precision (CV<2%) and accuracy val-
es (≥98.98%). The absence of interference of dextran and HPMC
as checked by comparing the data obtained from pure substance
BD and from samples spiked with polymer (Castellanos Gil et al.,
006a, 2008b,c).
The mechanism of drug release was analyzed according to,
iguchi (Eq. (2)), Korsmeyer (Eq. (3)) and Peppas-Sahlin (Eq. (4))
quations:
Qt
Q∞
= kh · t1/2 (2)
Qt
Q∞
= K · tn (3)
here Qt/Q∞ is the fraction of drug released; kh and K are kinetic
onstants; n is a diffusional exponent that depends on the release
echanism and on the shape of the swelling device tested. Val-
es of n=0.5 indicate Fickian release, values of 0.5 <n<1.0 indicate
n anomalous (non-Fickian or couple diffusion/relaxation) drug
elease, whereas values of n=1.0 show a case II (purely ero-
ion/relaxation controlled) drug release.
Qt
Q∞
= Kd · tm + Kr · t2m (4)
here Kd is the diffusional constant; Kr is the relaxational constant
ndm is the diffusional exponent that depends on geometric shape
f the releasing device through its aspect ratio (Ritger and Peppas,
987).
.4. Water uptake studies
The process of water penetration into the hydrophilic matrix
ablets was studied using a modiﬁed Enslin apparatus. This appa-
atus contains a fritted and a system to regulate the water level.
hen the tablet is placed on the fritted, the water is absorbed from
reservoir which is placed on a precision balance (Scatlec SBC 31,
ermany). The amount of water uptake at each time point was
ead from the balance as weight loss in the reservoir. The balance
s linked to a chart recorder and a personal computer. The rate of
ater penetration was expressed as the weight gain of the swelled
atrix, in percent (wt/wt) of penetrated ﬂuid with respect to dry
olymer. The kinetics of the water uptake into hydrophilic matri-
es was analyzed according to Davidsons and Peppas model using
r
t
a
B
ihe following equation:
= Ks · tn (5)
eing W the weight gained of the swelled matrix (water/dry
olymer); Ks, the kinetic constant of water penetration; t, the
enetration time; n, the exponent which depends on the water
enetration mechanism (Davidson and Peppas, 1986).
.5. Estimation of the percolation threshold
In order to estimate the percolation threshold, the behaviour
f the kinetic parameters (kh, K and Kr/Kd, respectively) and nor-
alized kinetic constants with respect to volumetric fraction and
olumetric fraction plus IP were studied.
According to the fundamental equation of percolation theory
Eq. (6)), if these parameters behave as critical properties, we can
xpect that
∝ S · (p − pc)n (6)
here X is the studied property; S is a constant; p is the volumetric
raction (or volumetric fraction plus IP) of the component; pc is the
ercolation threshold; (p−pc) is the distance to the percolation
hreshold and n is a critical exponent.
The kinetic parameters studied show a non-linear behaviour
s a function of the volumetric fraction of the excipients (plus or
ithout initial porosity). Two (or three) linear regressions have
een performed as an approximation for estimating the trend of
he parameter, one regression line below and the other above
he percolation threshold. The point of intersection between both
egression lines has been taken as an estimation of the percolation
hreshold (Miranda et al., 2006a,b; Fuertes et al., 2006; Castellanos
il et al., 2008b).
The initial porosity (IP)was calculatedusing the following equa-
ion:
(%) = 100 ×
(
Vt − (w · %LBD/LBD) − (w · %DT/DT) − (w · %HPMC/HPMC)
Vt
)
(7)
hereε(%) is the initial porosity inpercent;Vt is the tablets volume;
is the tablet weight; LBD, DT and HPMC are the drug, DT and
PMC density, respectively.
. Results and discussion
.1. Properties of binary and ternary matrix tablets at
ompression force 14 kN
Fig. 1 and Table 1 show IP, aspect ratio (ratio tablet diam-
ter/tablet thickness), % (v/v) of excipients (DT+HPMC), tablet
eight and tablet thickness obtained for the eight batches stud-
es (DT:HPMC-10 up to DT:HPMC-70) applying 14kN compression
orce (values for matrices DT:LBD were taken from previously
eported data (Castellanos Gil et al., 2008b)). Carr’s index is related
o powder ﬂowability, for which smaller values indicate better
owability. During the tabletting process, the enhancement of
owability could decrease the weight variation of tablets. On the
ther hand, the tensile strength of tablets is partly determined by
he compressibility of the powder bed and the postcompression
ecovery of tablets. Greater compressibility or plastic deformation
esults in higher tensile strength of tablets. The extent of plas-
ic deformation can be represented by yield pressure, for which
smaller value indicates a higher extent of plastic deformation.
y contrast, the postcompression recovery of tablets leads to an
ncrease in porosity accompanied by a decrease in tensile strength.
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uFig. 1. Initial porosity and aspect ratio for binary and ternary tablets.
acking/ﬂow ratio (values of Carr’s index, data showed in Fig. 2)
ecame more favorable (CI become lower values) with the increas-
ng of dextran’s amount in binary and ternary systems. Lost due to
riability for binary tablets (range 0.79–0.15%) were lower but in
he same range as ternary system (range 0.94–0.25%). CI and IP for
inary tablets were lower than for ternary systems, when tablets
ith equal % (v/v) excipients were compared. This can be due to
he differences in compressibility index of dextran (CI = 18.8) and
PMC (CI =24.6). As a consequence, when automatic machine will
e in use, the tablets containing this granulate (HPMC) have to be
anufactured at lower compression speed, in order to guarantee
n accurate ﬁlling of the machine die.
.2. Release proﬁles and release kinetics at compression force
4 kN
Fig. 3 shows the dissolution proﬁles for tablets of LBD with DT-
110-1-2 (DT 10% to DT 70%, wt/wt, particle size 150–200m)
nd with DT:HPMC (always in ratio 4:1, wt/wt). The value for rela-
ive standard deviation was lower than 5% for all points measured
n=12). Values for kinetic constants indicated that LBD release
s faster in binary system (kh binary system> kh ternary system,
or the same polymers content). This results agree well with our
revious observation when a synergy in the ability to control the
elease of propranolol hydrochloride was observed when we used
atio DT:HPMC 4:1 (wt/wt) (Castellanos Gil et al., 2006a). The
iguchi’s model as well as the non-linear regression of Korsmeyer
Fig. 2. Carr’s index values as a function of % (wt/wt) DT and DT:HPMC.
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iig. 3. Dissolution proﬁles for tablets prepared with different DT:HPMC and DT
ontents.
nd Peppas-Sahlin was employed as empiric methods to study the
eleased data. According to the aspect ratio obtained for all formu-
ations, values of 0.432<m<0.465 were found appropriate to be
sed in Eq. (4) (Ritger and Peppas, 1987). The results obtained are
hown in Table 2.
Values of diffusion exponent 0.588<n<0.784 (Korsmeyer equa-
ion) for dissolution proﬁle of sparingly soluble drug correspond
o anomalous diffusion mechanism and this well agrees with the
esults of other authors (Tahara et al., 1995; Miranda et al., 2006b).
his can be also observed in Peppas-Sahlin equation. The model
an identify the different contribution of the relaxation or erosion
echanism and of the diffusive mechanism. The values obtained
or Kr were lower than Kd for all the dissolution proﬁles.
.3. Water uptake assays and swelling kinetics
The degree of hydration of the polymer is one of the factors
etermining the degree and velocity of drug release from the
wellablematrices (Michailova et al., 2000). The characterization of
ater-sorption capabilities is the ﬁrst step towards understandinghe mechanisms of drug release from DT and DT:HPMC matrices.
The results of the water uptake measurements are shown in
ig. 4. An increase in the rate of water uptake/dry polymer can be
bserved when the excipients concentration decreases. A change
n water uptake kinetic was found between 20% and 30% (wt/wt)
Table 2 
Dissolution data for ternary and binary matrices prepared with DT:HPMC:LBD and DT:LBD. 
Batch 
DT:HPMC-10 
DT:HPMC-15 
DT:HPMC-20 
DT:HPMC-30 
DT:HPMC-40 
DT:HPMC-50 
DT:HPMC-60 
DT:HPMC-70 
Korsmeyer 
K(%min-n) 
6.38 
Higuchi 
kh (ll:min-112) 
8.39 
6.45 
4.88 
3.57 
3.18 
2.76 
2.61 
2.36 
n 
0.588 
r2 
0.9980 
0.9770 
0.9710 
0.9679 
0.9739 
0.9799 
0.9778 
0.9640 
,2 SQR• 
0.9999 1.08 
SQR 
5.74 
58.32 
50.35 
46.81 
64.10 
39.32 
39.36 
49.79 
Peppas-Sahlin 
K,i (%min-m) K, (%min-2m) r2 SQR• 
7.04 0.86 0.9999 1.80 DT:HPMC-10 
DT:HPMC-15 
DT:HPMC-20 
DT:HPMC-30 
DT:HPMC-40 
DT:HPMC-50 
DT:HPMC-60
DT:HPMC-70
2.82 0.784 0.9991 4.19 3.95 0.67 0.9991 5.43 
1.76 0.747 0.9990 3.42 2.40 0.57 0.9930 2.35 
1.27 0.740 0.9999 0.68 1.78 0.34 0.9999 0.31 
1.34 0.700 0.9992 3.18 2.08 0.25 0.9999 0.40 
1.41 0.651 0.9999 3.43 2.14 0.21 0.9980 7.95 
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1.26 0.663 0.9991 1.28 
0.79 0.730 0.9999 2.83 
uares residual; kh , K, Kd and K,: kinetic constants for each mode); n: diffusional e
 correlation for each mode) ( applied compression force for ail experiment 14 kN). 
s (for DT: HPMC: LBD tablets ). This range corresponds to 
point which has been observed in the release kinetics 
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Table3 
Water uptake d
contents (10-7
Batch 
DT:HPMC-10
DT:HPMC-15
DT:HPMC-20
DT:HPMC-30
DT:HPMC--40
DT:HPMC-50
DT:HPMC-60
DT:HPMC-70
K,: kinetic co
exponent whic
correlation, 
• Sum of squ 0.23 0.9998 2.28 
 0.28 0.9999 1.00 
ent of Korsmeyer mode); m: exponent of Peppas-Sahlin mode); r2 : 
ifferences in hydrophilicity of polymers (DT> HPMC) 
 of the ta blets. Furthermore a reduction of around 10% 
 the critical point has been obtained with respect to 
ets (see Fig. 4). 
r uptake data were subjected to the Davidson and Pep­
o calcula te the rate of water penetration. The results are 
ble 3. The high value of swelling constant (Ks = 17.31 % 
or DT: HPMC-10 suggests burst swelling. The exponent
 is in the range O. 735 < n < 1 which suggests an anoma­
plex behaviour (the rate of diffusion of the liquid is 
igher than that of relaxation of the polymer segment). 
our agrees well with the previously discussed kinetic 
 DT:HPMC-50 (corresponding to 42.81%, v/v DT plus 
HPMC. respectively) an small change of the system was 
 .. a litter increment of Ks values (Ks = 4.24 ± 0.05) with a 
eduction in exponent (n = 0.772) values. In this case the 
 threshold corresponding to pure DT (around 44.75%, 
nos Gil et al., 2008b)). could be the possible reason for 
mena. ion of the excipient percolation threshold
ercolation theory is applied to binary pharmaceuti­
, two percolation thresholds are expected; the drug 
ata for binary and ternary matrices prepared with different polymer 
0, wt/wt). 
K, (%min-") n r2 SQR• 
 17.31 ± 0.86 0.903 0.9990 94.39 
 11.10 ± 0.66 0.901 0.9999 73.08 
 7.40 ± 0.45 0.903 0.9999 86.39 
 3.59 ± 0.76 0.955 0.9990 46.09 
 2.83 ± 0.32 0.877 0.9999 24.45 
 4.24 ± 0.05 0.772 0.9991 4.56 
 1.09 ± 0.29 0.948 0.9999 2.01 
 0.73 ± 0.73 0.735 0.9960 21.60 
nstant of water penetration; t: penetration time; n: diffusional 
h depends on the water penetration mechanism, r2: coefficient of 
ares residual (applied compression force 14 kN). 
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Dercolation threshold and the excipient percolation threshold.
n hydrophilic matrices the drug threshold is less evident than
he excipient threshold which is responsible for the release con-
rol (Miranda et al., 2006a,b; Fuertes et al., 2006). According
o Miranda’s et al. results, the percolation threshold for LBD is
round 56% (v/v) of active pharmaceutical ingredient (this value
as obtained near to the batch DT:HPMC-15, where % (v/v) poly-
ers =15.91% and IP =28.95% and batch DT-15, where % (v/v)
olymer =16.62% and IP =25.33%, respectively).
In order to estimate the percolation threshold of the mixture of
xcipients DT:HPMC (ratio 4:1, wt/wt), the evolution of the release
arameters has been studied as a function of the sum of the excipi-
nt volumetric percentage alone or added with the initial porosity
IP). Fig. 5 shows changes in the different kinetic parameters as
ell as in the normalized kinetic parameters as a function of %
v/v) of excipients and % (v/v) of excipients plus IP. Two linear
egressions have been performed as an approximation. The per-
olation threshold has been estimated as the point of intersection
a
t
s
(
o
Fig. 5. Evolution of different kinetic and normalized kinetic constants as aetween both regression lines (X1). The values of the excipient per-
olation thresholds estimated for all the batches studied, based on
he behaviour of the kinetic parameters, are shown in Table 4.
The Higuchi’s slope, as well as K and the ratio Kr/Kd
nderwent an important change between DT:HPMC:LBD-20 and
T:HPMC:LBD-30 Aexcipient percolation threshold. This means
hat between 22.34% (v/v) and 33.10% (v/v) of polymers mix-
ure DT:HPMC (4:1, wt/wt), a percolating cluster of the excipients
ould be obtained which results in a control of the drug release.
pposite to the Higuchi’s model parameters, the kinetic constants
erived from non-linear methods show a second change around
T:HPMC:LBD-50 (seeK andKr/Kd values, Fig. 5 andTables 2 and4).
According to percolation theory, the studied properties showcritical behaviour as a function of the volumetric fraction of
he components. A critical point (for intersection of linear regres-
ion, see Table 4) has been found between 21.08% and 25.17%
v/v) of DT:HPMC (corresponding to the range 44.75–47.66%, v/v
f DT:HPMC plus IP). This fact indicates that above this range an
function of the excipients volumetric fraction plus and without IP.
Table 4
The values of the excipients percolation thresholds, according to the kinetic and normalized kinetic parameters used.
Kinetic parameters Equations r2 *Intersection
(kh) versus (%, v/v excipients) Y1=−0.3257x+11.998 0.9720 X1=25.17
Y2=−0.0328x+4.6254 0.9820
(kh/%, v/v excipients) versus (%, v/v excipients) Y1=−0.0498x+1.2894 0.9449 X1=23.48
Y2=−0.002x+0.1666 0.9483
(K) versus (%, v/v excipients) Y1=−0.3910x+10.051 0.8696 X1=22.61
Y2=0.0065x+1.0624 0.9997
Y3=−0.0388x+3.5639 0.7896 X2=55.22
(K/%, v/v excipients) versus (%, v/v excipients) Y1=−0.0431x+0.9888 0.8426 X1=22.12
Y2=−0.0006x+0.0579 0.9918
Y3=−0.0010x+0.0784 0.9324 X2=53.94
Ratio (Kr/Kd) versus (%, v/v excipients) Y1=0.0102x+0.0097 0.9998 X1=22.24
Y2=−0.0046x+0.3389 0.9699
Y3=0.0098x−0.4472 0.7101 X2=54.59
Ratio ((Kr/Kd)/(%, v/v excipients)) versus (%, v/v excipients) Y1=−0.00004x+0.011 0.8426 X1=21.08
Y2=−0.0003x+0.0161 0.9227
Y3=0.0001x−0.00471 0.9324 X2=53.18
(kh) versus (%, v/v excipients + IP) Y1=−0.7427x+38.390 0.9475 X1=46.64
Y2=−0.0411x+5.6655 0.9652
(kh/%, v/v excipients + IP) versus (%, v/v excipients + IP) Y1=−0.0209x+1.0517 0.9507 X1=46.84
Y2=−0.0013x+0.1336 0.9549
(K) versus (%, v/v excipients + IP) Y1=−0.8436x+39.573 0.7516 X1=45.46
Y2=0.0095x+0.7781 0.9995
Y3=−0.0423x+4.2997 0.9371 X2=67.98
(K/%, v/v excipients + IP) versus (%, v/v excipients + IP) Y1=−0.0218x+1.0143 0.7601 X1=45.30
Y2=−0.0002x+0.0358 0.9928
Y3=−0.0008x+0.0753 0.9823 X2=65.83
Ratio (Kr/Kd) versus (%, v/v excipients + IP) Y1=0.0234x−0.8194 0.9811 X1=44.75
Y2=−0.0068x+0.5413 0.9715
Y3=0.0109x−0.6522 0.8852 X2=67.42
Ratio ((Kr/K )/(%, v/v excipients + IP)) versus (%, v/v excipients + IP) Y1=0.0004x−0.0149 0.9608 X1=47.66
Y
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* Probability p<0.05
nﬁnite cluster of the excipients has been formed, which controls
he penetration of the liquid into the matrices and the release of
rug form these systems. For non-linear methods a second but less
ronounced critical point was observed (X2 in Table 4) between
3.18% and 55.22% (v/v) DT:HPMC (65.83–67.98%, v/v DT:HPMC
lus IP), this point corresponds to 42.81% (v/v) of pure DT polymer,
.e., dextran percolation threshold (Castellanos Gil et al., 2008b). On
he other hand percolation threshold for LBD observed as inﬂex-
on point around 16.72% (v/v) of DT and 15.91% (v/v) of DT:HPMC
as found easier from the Higuchi’s slope representation (Kh) and
ven determined in DT batches (see Fig. 5 case B) as a similar value
eported by Miranda et al.
The results obtained from the kinetics analysis are in agreement
ith the release proﬁles, indicating a clear change in the release
ate and mechanism from matrices containing 70% (wt/wt) of drug
30%, wt/wt of DT:HPMC). The existence of a critical point can be
ttributed to the excipient percolation threshold.
.5. Effect of tablets initial porosityIn practice, the percolation threshold of excipient is the most
mportant for matrices system. Nevertheless, the percolation
hreshold of pores is also interesting to consider in the com-
action process because the role of pores in swelling and erosion
rocess (Holman and Leuenberger, 1991; Miranda et al., 2006a).
i
s
w
o
h2=−0.0002x+0.0137 0.9651
3=0.0001x−0.0065 0.8599 X2=67.33
bove some compression force, the pores do not form any-
ore a continuous network. This is the percolation threshold of
ores.
Recent studies have found the existence of a sample-spanning
luster of excipient plus pores in the hydrophilic matrix before the
atrix is placed in contact with the liquid. This cluster conditions
he release kinetics of the drug (Miranda et al., 2006a,b; Fuertes et
l., 2006; Castellanos Gil et al., 2008b).
Batches for DT:HPMC-10 up to DT:HPMC-70, with three initial
orosity ranges: 0–10%, 10–20%and20–30%were studied. Thedata
btained from the corresponding dissolution assays were also ﬁt-
ed toHiguchi’smodel. Fig. 6 shows changes in the obtained kinetic
arameters as a function of % (v/v) of excipients. The DT:HPMC
hresholds were estimated as described in Section 2: two linear
egressions have been performed. The percolation threshold has
een estimated as the point of intersection between both regres-
ion lines.
Whendifferent IP series are compared, thevaluesofkh increased
s increased IP. Nevertheless a not signiﬁcant difference (p<0.05)
n percolation thresholds (intersection points A=21.98%, v/v excip-
ents and B=21.99%, v/v excipients in Fig. 6) was achieved for
eries IP 0–10 and IP 10–20. Despite some statistical signiﬁcance
as found for the percolation threshold (C=24.17%, v/v excipients)
f the matrices with 20–30% IP. As Fig. 6 shows, little difference
as been found for the percolation threshold of tablets contain-
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Rig. 6. Changes in the kinetic parameters as a function of % (v/v) of excipients for
hree series of IP (0–10%, 10–20% and 20–30% IP).
ng strong differences in initial porosity, and therefore in tablet
ardness.
Batches DT:HPMC-50, have been supposed, according to the
ehaviour of the non-linear kinetic parameters (Korsmeyer and
eppas-Sahlin), to be very close to the percolation threshold of the
ure dextran. In Fig. 6, these lots reﬂect a slight deviation from
inearity (point D).
Minimizing the IP of the matrix system also decreased intersti-
ial channels and, as a consequence decreases the diffusion rate.
herefore, a slower release of drug can be observed even from the
nitial time.
The excipient percolation threshold is the border between a fast
elease of the drug (below the threshold) and a drug release con-
rolled by the formation of a coherent gel layer (above the excipient
ercolation threshold). Therefore the knowledge of this threshold
ill allow us to avoid the preparation of a number of unnecessary
atches, during the development of a pharmaceutical formulation,
esulting in a reduction of the time to market.
. Conclusion
Ternary controlled release tablets of lobenzarit disodium have
een developed with a mixture of two polymers: native dextran
110-1-2 (Mw 2×106): HPMC K4M CR with a relative excipi-
nts/LBD particle size of 4.17. These systems should be formulated
ith polymer content above 20% (wt/wt) (corresponding to around
2.34%, v/v) to obtain a control of the drug release. This value corre-
ponds to the percolation threshold of the excipients. Anomalous
echanism for water uptake and dissolution proﬁle of LBD from
hese systems can be expected.
The employ of a mixture dextran:HPMC (4:1, wt/wt) resulted in
reductionof thepercolation threshold from44.75% to25.17% (v/v)
xcipients, with respect to binary DT:LBD matrices. The ternary
atrices showed better compressibility properties with respect to
PMC:LBD tablets. Initial porosity has an inﬂuence in the percent
f lobenzarit disodium dissolved at each moment, nevertheless
howed little inﬂuence in the excipient percolation threshold of
he studied hydrophilic matrix tablets.
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DThpmc20% w/wDThpmc30% w/wDThpmc40% w/wDThpmc50% w/wDThpmc60% w/wDThpmc70% w/wDthpmc15% w/wDThpmc10% w/wDt20% w/w DT30% w/w DT40% w/w DT50% w/w DT60% w/w DT70% w/w DT15% w/w DT10% w/w
peso (g) 0,1875 0,2142 0,25 0,3 0,375 0,5 0,176 0,166 0,1875 0,2142 0,25 0,3 0,375 0,5 0,176 0,166
fármaco p/p(tanto por uno) 0,8 0,7 0,6 0,5 0,4 0,3 0,85 0,9 0,8 0,7 0,6 0,5 0,4 0,3 0,85 0,9
HPMC p/p(tanto por uno) 0,04 0,06 0,08 0,1 0,12 0,14 0,03 0,02 0 0 0 0 0 0 0 0
DT p/p(tanto por uno) 0,16 0,24 0,32 0,4 0,48 0,56 0,12 0,08 0,2 0,3 0,4 0,5 0,6 0,7 0,15 0,1
diámetro (cm) 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
altura (cm) 0,1618 0,1871 0,2213 0,2683 0,3407 0,4916 0,16 0,148 0,1534 0,1817 0,2139 0,2683 0,3283 0,4357 0,152 0,146
sup (cm2) 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398 0,785398
volumen (cm3) 0,1270774 0,14694797 0,17380858 0,21072228 0,2675851 0,38610166 0,12566368 0,1162389 0,12048005 0,14270682 0,16799663 0,21072228 0,25784616 0,34219791 0,1193805 0,11466811
A (g/cm3) 1,18038301 1,02036118 0,8630184 0,71183739 0,56056933 0,38849872 1,19047922 1,28528397 1,24501937 1,05068562 0,89287504 0,71183739 0,58174222 0,43834283 1,25313602 1,3028906
poros. Total 77,6569495 66,8901929 56,4379506 46,1035323 36,3350941 31,3649607 84,0935355 89,1872518 76,5973803 66,1433205 55,2443588 46,4783918 34,389975 23,097749 83,3728082 89,1153668
% porosid inicial 22,9842764 19,6293693 16,4648891 13,1328334 10,3707897 13,370578 28,9532288 29,6558035 18,9308971 17,4779375 13,888405 13,5076929 7,44499017 2,79469982 25,3303801 28,7684191
%v/v fármaco 54,6726731 47,2608236 39,9730615 32,9706989 25,9643044 17,9943826 55,1403067 59,5314484 57,6664831 48,665383 41,3559538 32,9706989 26,9449848 20,3030491 58,0424281 60,3469476
%v/v HPMC 4,59293001 6,80618909 8,95479531 11,0791812 13,0872218 14,108903 3,26979873 2,22271331 0 0 0 0 0 0 0 0
%v/v DT 17,7501205 26,303618 34,607254 42,8172866 50,5776841 54,5261363 12,6366658 8,59003489 23,4026197 33,8566795 44,7556412 53,5216082 65,610025 76,902251 16,6271918 10,8846332
dens. Fco 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159 2,159
dens. HPMC 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285 1,285
dens. DT 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33 1,33
dens. Relativa 0,77015724 0,80370631 0,83535111 0,86867167 0,8962921 0,86629422 0,71046771 0,70344197 0,81069103 0,82522062 0,86111595 0,86492307 0,9255501 0,972053 0,7466962 0,71231581
aspect ratio 6,18046972 5,34473544 4,51875282 3,72717108 2,93513355 2,03417413 6,25 6,75675676 6,51890482 5,50357733 4,67508181 3,72717108 3,04599452 2,29515722 6,57894737 6,84931507
10% 15%
asp Ratio para dThpmc 10 y 15% 6,75675676 6,25
% POROSIDAD INiCIAL
v/vDT+HPMC 22,3430505 33,1098071 43,5620494 53,8964677 63,6649059 68,6350393 15,9064645 10,8127482
v/vDT+HPMC + IP 45,3273269 52,7391764 60,0269385 67,0293011 74,0356956 82,0056174 44,8596933 40,4685516
